Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)

N/AUnknownNCT03178812

Hillel Yaffe Medical Center30 enrolled

Overview

This study aims to find a correlation between cytokines levels and malignancy potential of different cystic types.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Pancreatic Cancer

Interventions

EUS with fine-needle aspiration of pancreatic cystPROCEDURE

EUS with fine-needle aspiration

Laboratory Blood testDIAGNOSTIC_TEST

Laboratory Blood Test

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with pancreatic cyst Exclusion Criteria: * None

Locations (1)

Hillel Yaffe Medical

Hadera, Israel

Outcomes

Primary Outcomes

Prediction of malignant potential of pancreatic cyst by measuring Interleukin levels

Interleukin 1,8,10 will be measured quantitatively by an enzyme-linked immunosorbent assay. The same interleukins levels will be measured in serum of same patients and control group. Results will enable classification of cysts to either high or low risk malignancy potential.

Time frame: Two years

Prediction of malignant potential of pancreatic cyst by measuring TNF levels

TNF levels will be measured quantitatively by an enzyme-linked immunosorbent assay. The same TNF levels will be measured in serum of same patients and control group. Results will enable classification of cysts to either high or low risk malignancy potential.

Time frame: Two years

Central Contacts

Yael Kopelman, MD

CONTACT

972-50-6246840 yaelk@hy.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.